Skip to main content
Top
Published in: Clinical Rheumatology 1/2012

01-01-2012 | Letter to the Editor

Comment on “Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA”

Authors: Liang-Ping Ye, Xue-Mei Zhan, Hua-Qing Hu

Published in: Clinical Rheumatology | Issue 1/2012

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Metawi SA, Abbas D, Kamal MM, Ibrahim MK (2011) Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 30(9):1201–1207PubMedCrossRef Metawi SA, Abbas D, Kamal MM, Ibrahim MK (2011) Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 30(9):1201–1207PubMedCrossRef
2.
go back to reference Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP, Wang GH, Wu GC, Su H, Pan FM, Li WX, Li LH, Chen GP, Ye DQ (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37(1):81–85PubMedCrossRef Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP, Wang GH, Wu GC, Su H, Pan FM, Li WX, Li LH, Chen GP, Ye DQ (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37(1):81–85PubMedCrossRef
3.
go back to reference Mei Y, Pan F, Gao J, Ge R, Duan Z, Zeng Z, Liao F, Xia G, Wang S, Xu S, Xu J, Zhang L, Ye D (2011) Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol 30(2):269–273PubMedCrossRef Mei Y, Pan F, Gao J, Ge R, Duan Z, Zeng Z, Liao F, Xia G, Wang S, Xu S, Xu J, Zhang L, Ye D (2011) Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol 30(2):269–273PubMedCrossRef
4.
go back to reference Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T (2008) Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 18(1):15–22PubMedCrossRef Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T (2008) Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 18(1):15–22PubMedCrossRef
5.
go back to reference Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13(4):R126PubMedCrossRef Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13(4):R126PubMedCrossRef
6.
go back to reference Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ (2011) Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Ann Rheum Dis 70(9):1550–1555PubMedCrossRef Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ (2011) Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Ann Rheum Dis 70(9):1550–1555PubMedCrossRef
Metadata
Title
Comment on “Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA”
Authors
Liang-Ping Ye
Xue-Mei Zhan
Hua-Qing Hu
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1868-1

Other articles of this Issue 1/2012

Clinical Rheumatology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.